References
- Iosif CS, Beckassy Z. Prevalence of urogenito-symptoms in the late menopause. Acta Obstet Gynecol Scand 1984; 63: 257–60
- Molander U, Milsom I, Ekelund P, Mellström D. An epidemiological study of urinary incontinence and related urogenital symptoms in elderly women. Maturitas 1990; 12: 51–60
- Heimer GM. The urogenital estrogen deficiency syndrome. Pharmacological treatment of the climacteric syndrome. National Board of Health and Welfare. Drug, Information Committee, Sweden 1990; 3: 23–7
- Pharmacological treatment of the climacteric syndrome. Recommendations from the group. Pharmacological treatment of the climacteric syndrome. National Board of Health and Welfare. Drug. Information Committee, Sweden 1990; 3: 157–66
- Gunbjørud AB, Aanderud SJ, Flottorp S, et al. Bruk av østrogen i og etter overgangsalderen. Uttalelsen fra konsensuskonferansen om bruk av østrogen i og etter overgangsalderen. (Use of oestrogen during and after climacterium. Report from a consensus conference concerning use of oestrogen during and after climacterium). Soria Moria, Oslo, 27–29 November 1990. Tidsskr Nor Lægeforen 1991; 111: 75–7
- Heimer GM. Oestriol in the postmenopause. Thesis from the Faculty of Medicine, Uppsala University, Sweden 1986; 30
- Brandberg Å, Mellström D, Samsioe G. Peroral östriol-behandling til äldre kvinnor med urogenitala infektioner. (Peroral oestriol treatment of elderly women with urogenital infections). Läkartidningen 1985; 82: 3399–401
- Privette M, Cade R, Peterson J, Mars D. Prevention of recurrent urinary tract infections in postmenopausal women. Nephron 1988; 50: 24–7